Prevenotics

Technology empowering prevention beyond diagnosis

South Korea · Founded 2021

Founded
2021
Business Model
B2B
Last Round
SeedApr 2024
Rounds
1

About

Prevenotics develops AI medical diagnostic software that improves cancer diagnosis accuracy and identifies pre-cancerous risks so clinicians can practice preventive diagnosis. The company builds endoscopic image analysis tools, including Venotics Lite and Preveno-G Lite, which are Class II digital medical devices certified in Korea, to detect gastric and other GI cancer signals from endoscopy data. Its mission is innovative cancer preventive management for high-risk patients, reducing severe gastric cancer cases and unnecessary biopsies through AI-assisted screening.

Summary

Prevenotics is a Healthcare company based in South Korea, founded in 2021. Its most recent funding was a Seed round in Apr 2024. Investors include 500 Global.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundApr 2024

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prevenotics on Indexed.vc
<a href="https://indexed.vc/companies/prevenotics"><img src="https://indexed.vc/api/badge/company/prevenotics" alt="Prevenotics on Indexed.vc" width="260" height="76" /></a>